Home/Filings/4/0001179110-19-000327
4//SEC Filing

Misfeldt Dayton 4

Accession 0001179110-19-000327

CIK 0001061027other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 7:15 PM ET

Size

5.4 KB

Accession

0001179110-19-000327

Insider Transaction Report

Form 4
Period: 2018-12-31
Misfeldt Dayton
Director10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-12-31+200,000200,000 total
    Exercise: $0.42Exp: 2028-12-31Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The option vests monthly over six (6) months in equal monthly installments subject to optionee's continuing service to the Company.

Issuer

SUNESIS PHARMACEUTICALS INC

CIK 0001061027

Entity typeother

Related Parties

1
  • filerCIK 0001461466

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:15 PM ET
Size
5.4 KB